-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The company has obtained another 6 production approvals.
Category:
Time：2019-04-23
Recently, our company has obtained six new products in the peritoneal dialysis solution category, namely: low-calcium peritoneal dialysis solution (lactate-G1.5%), low-calcium peritoneal dialysis solution (lactate-G2.5%), low-calcium peritoneal dialysis solution (lactate-G4.25%), peritoneal dialysis solution (lactate-G1.5%), peritoneal dialysis solution (lactate-G2.5%), and peritoneal dialysis solution (lactate-G4.25%).
Recently, our company has obtained six new products in the peritoneal dialysis solution category, namely: low-calcium peritoneal dialysis solution (lactate-G1.5%), low-calcium peritoneal dialysis solution (lactate-G2.5%), low-calcium peritoneal dialysis solution (lactate-G4.25%), peritoneal dialysis solution (lactate-G1.5%), peritoneal dialysis solution (lactate-G2.5%), and peritoneal dialysis solution (lactate-G4.25%).
Peritoneal dialysis uses the peritoneum as a dialysis membrane. Dialysate is infused into the abdominal cavity, allowing for the exchange of substances between the blood in the peritoneal capillaries and the dialysate. Metabolic waste products and excess fluid retained in the body are removed from the body along with the spent dialysate, while the dialysate replenishes essential substances. By repeatedly infusing fresh dialysate into the abdominal cavity, it is possible to achieve therapeutic goals such as toxin removal, dehydration, correction of acidosis, and normalization of electrolyte imbalances.
Today, peritoneal dialysis has evolved into an important component of renal replacement therapy, alongside hemodialysis and kidney transplantation, owing to its simple and convenient operation and proven efficacy. Compared with developed countries, however, the utilization rate of peritoneal dialysis in China remains relatively low, leaving considerable room for market growth.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license